Biogen
BIIB
$261.22
Share price
-1.85%
Change (1 day)
23.85%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Number of shares outstanding for Biogen (BIIB)
Number of shares outstanding as of March 2023 : 144,100,000
According to Biogen's latest financial reports and stock price the company's current number of shares outstanding is 144,100,000. At the end of 2022 the company had 144,100,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Biogen from 2001 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 0.14 B | -1.91% |
| 2021 | 0.14 B | -4.42% |
| 2020 | 0.15 B | -13.55% |
| 2019 | 0.17 B | -11.01% |
| 2018 | 0.19 B | -5.53% |
| 2017 | 0.21 B | -2.35% |
| 2016 | 0.21 B | -1.72% |
| 2015 | 0.22 B | -6.4% |
| 2014 | 0.23 B | -0.34% |
| 2013 | 0.23 B | -0.14% |
| 2012 | 0.23 B | -2.61% |
| 2011 | 0.24 B | 1.29% |
| 2010 | 0.23 B | -16.98% |
| 2009 | 0.28 B | -0.85% |
| 2008 | 0.29 B | 0.85% |
| 2007 | 0.28 B | -14.51% |
| 2006 | 0.33 B | 0.44% |
| 2005 | 0.33 B | 0.53% |
| 2004 | 0.33 B | 122.99% |
| 2003 | 0.15 B | 0.41% |
| 2002 | 0.14 B | 0.75% |
| 2001 | 0.14 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,627,900,000 | 1,723.66% | 🇺🇸 USA |
 Pfizer PFE | 5,607,000,000 | 3,791.05% | 🇺🇸 USA |
 AbbVie ABBV | 1,769,181,294 | 1,127.75% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 271.27% | 🇺🇸 USA |
 Sanofi SNY | 2,507,000,000 | 1,639.76% | 🇫🇷 France |
 Gilead Sciences GILD | 1,255,000,000 | 770.92% | 🇺🇸 USA |
 Illumina ILMN | 157,000,000 | 8.95% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 24,290,000 | -83.14% | 🇺🇸 USA |
 Qiagen QGEN | 227,716,000 | 58.03% | 🇳🇱 Netherlands |
 Bio-Rad Laboratories BIO | 29,683,000 | -79.40% | 🇺🇸 USA |